Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Mar 28, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 116,959 --
Mar 28, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,163 --
Mar 28, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 28, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 6,860 $6.69
Mar 28, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,326 --
Mar 28, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Grant, award or other acquisition pursuant to Rule 16b-3(d) 233,918 --
Mar 28, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 28, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 28, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 28, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 28, 2017
President & COO
President & COO Grant, award or other acquisition pursuant to Rule 16b-3(d) 66,717 --
Mar 28, 2017
President & COO
President & COO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 4,562 $6.69
Mar 28, 2017
President & COO
President & COO Grant, award or other acquisition pursuant to Rule 16b-3(d) 155,556 --
Mar 25, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,410 $6.61
Mar 22, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Mar 22, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 2,819 $6.42
Mar 22, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 22, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 22, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 6,838 $6.42
Mar 22, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 22, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 22, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 22, 2017
President & COO
President & COO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,419 $6.42
Feb 18, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Feb 18, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 2,471 $5.91

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.